categories dietary-supplements 
Quality Matters
MARCH 8, 2024
Navigating “Trending” Supplements Last year, we witnessed growing interest in consumer health and wellness products that were trending on social media. For some products – like dietary supplements – an impulse buy can be dangerous. adults take supplements and 55% are considered regular users.
Express Pharma
OCTOBER 27, 2023
SETU aims to grow their business 30 times over the next five years, capitalising on strong category and channel growth. Nihaal Mariwala, Founder, SETU shared, “I am grateful for the support from our investors, who share a common vision of revolutionising the supplements category with novel products and a superior customer experience.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fuld & Company Blog
FEBRUARY 7, 2024
A Mid-West-based private equity firm with over $3 billion in assets under management required a detailed analysis of the expanding US dietary supplements market to inform their decision on a potential acquisition. The post Powering a US dietary supplements acquisition appeared first on Fuld & Co.
FDA Law Blog: Biosimilars
MARCH 15, 2023
s Ricardo Carvajal will be moderating a panel on “The Use of Bioactive Substances in Food and Dietary Supplements” during the Food and Drug Law Institute (FDLI) Food and Dietary Supplement Safety and Regulation Conference. Hyman, Phelps & McNamara, P.C.’s
RX Note
SEPTEMBER 10, 2023
CKD Staging Staging of CKD is done according to Cause of disease 6 categories of GFR (G stages) 3 categories of albuminuria (A stages) The purpose of CKD staging is to guide management, including stratification of risk for progression and complications of CKD. Also, a higher dietary protein intake (1.0-1.2 g/kg/day (0.6-0.8
PharmaShots
JUNE 29, 2023
The company focuses on developing organic spirulina and microalgae products under its Nutraceutical division as a type of dietary supplement. The company's main asset in the nutritional supplements division is Organic Spirulina. percent from 2021 to 2030. In comparison to 2021, Parry's revenue increased by 4.92% in 2022.
FDA Law Blog: Biosimilars
JANUARY 1, 2024
The FDA compliance data, sorted by category, shows there were 159 Warning Letters issued to drug manufacturers or sponsors during 2023, with 161 issued in calendar year 2022. We are unable to determine whether the number of such Warning Letters issued during the entire year represents a significant increase over 2022.
Expert insights. Personalized for you.
98 
Let's personalize your content